SCHEMBL31076554

SCHEMBL31076554

NC1CCN(Cc2cccc3c2CN(C2CCCNC2)C3=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 10/20 0.47
▸ HTR2C P28335 10/20 0.47
▸ HTR2A P28223 7/20 0.47
▸ MAPK1 P28482 1/20 0.45
▸ PARP1 P09874 5/20 0.44
▸ HTR3E A5X5Y0 1/20 0.43
▸ HTR3B O95264 1/20 0.43
▸ HTR3A P46098 1/20 0.43
▸ TMEM97 Q5BJF2 1/20 0.43
▸ HTR3D Q70Z44 1/20 0.43
▸ HTR3C Q8WXA8 1/20 0.43
▸ PARP2 Q9UGN5 2/20 0.37
▸ CDK4 P11802 1/20 0.36
▸ CRBN Q96SW2 2/20 0.35
▸ IKZF3 Q9UKT9 2/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ TNF P01375 1/20 0.35
▸ IL1B P01584 1/20 0.35
▸ IKZF1 Q13422 1/20 0.35
▸ DDB1 Q16531 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30459137 0.88 HTR2B (0.47) HTR2BHTR2CHTR2AMAPK1PARP1
SCHEMBL30459293 0.84 HTR2B (0.47) HTR2BHTR2CHTR2APARP1HTR3E
SCHEMBL30458971 0.84 HTR2B (0.44) HTR2BHTR2CHTR2AMAPK1PARP1
SCHEMBL30458409 0.84 HTR2B (0.44) HTR2BHTR2CHTR2AMAPK1PARP1
SCHEMBL30458453 0.83 HTR2B (0.47) HTR2BHTR2CHTR2AMAPK1PARP1
SCHEMBL30458591 0.82 HTR2B (0.47) HTR2BHTR2CHTR2AMAPK1PARP1
SCHEMBL30459956 0.82 HTR2B (0.50) HTR2BHTR2CHTR2AMAPK1PARP1
SCHEMBL30458487 0.81 CRBN (0.42) HTR2BHTR2CHTR2APARP1HTR3E
SCHEMBL660471 0.78 HTR2B (0.62) HTR2BHTR2CHTR2AMAPK1PARP1
SCHEMBL30698072 0.78 HTR2B (0.62) HTR2BHTR2CHTR2AMAPK1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4446324-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2024-10-16 — — EP claimed
Send feedback